Abstract:This review discusses recent advances in sequencing technologies at a single‐cell level, which are being employed for delineating the heterogeneity within different cellular subtypes in pancreatic tumors. As pancreatic tumors are highly heterogenous, further understanding of the differences within cellular subtypes will be crucial for better understanding the pathogenesis of this debilitating disease. It will be further useful to develop clinically relevant classification system for pancreatic tumors which could be used to stratify patients for personalized medicine approach using emerging targeted therapies. Background Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies in the world, for which the mortality is almost as high as the disease incidence and is predicted to be the second‐highest cause of cancer‐related deaths by 2030. These cancerous tumors consist of diversified gene expressions within the different cellular subpopulations that include neoplastic ductal cells, cancer‐associated fibroblasts, and immune cells, all of which collectively facilitate cellular heterogeneity in the PDAC tumor microenvironment (TME). Active intratumoral interaction within the cell populations in TME induces the proliferation of cancerous cells, accounting for tumorigenesis and rapid metastasis. Methods This review will focus on novel findings uncovering PDAC heterogeneity in different cellular subpopulations using single‐cell RNA‐sequencing (scRNA‐seq) and other single‐cell analysis technologies. It will further explore the emerging role of single‐cell technologies in assessing the role of different subpopulations of neoplastic ductal cells, cancer‐associated fibroblasts, and immune cells in PDAC progression. Results and Conclusion The application of scRNA‐seq in PDAC has started to unveil associations between disease progression and heterogeneity in pancreatic TME and could influence future PDAC treatment. Recent advances in scRNA‐seq have uncovered comprehensive analyses of heterogeneous ecosystems present within the TME. These emerging findings underpins further need for a more in‐depth understanding of intratumoral heterogeneity in the PDAC microenvironment.

A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal Cancer

Intratumor Heterogeneity: A New Perspective on Colorectal Cancer Research

Single-cell sequencing technology in colorectal cancer: a new technology to disclose the tumor heterogeneity and target precise treatment

Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome

Using Single‐cell Multiple Omics Approaches to Resolve Tumor Heterogeneity

Panomics reveals patient individuality as the major driver of colorectal cancer progression

From tumour heterogeneity to advances in precision treatment of colorectal cancer

Application of Single-Cell Sequencing Technology in Research on Colorectal Cancer

Incorporating Novel Technologies in Precision Oncology for Colorectal Cancer: Advancing Personalized Medicine

Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma

Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer

A Richer Understanding of Intratumoral Heterogeneity: Single-Cell Genomics Put It Within Reach

Investigating intratumour heterogeneity by single-cell sequencing.

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis

Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single‐cell analysis

Single-cell integration and multi-modal profiling reveals phenotypes and spatial organization of neutrophils in colorectal cancer

Deciphering colorectal cancer immune microenvironment transcriptional landscape on single cell resolution – A role for immunotherapy

Multi-region and Single-Cell Sequencing Reveal Variable Genomic Heterogeneity in Rectal Cancer

Intra-tumor Genetic Heterogeneity in Rectal Cancer.

Mast Cells, microRNAs and Others: The Role of Translational Research on Colorectal Cancer in the Forthcoming Era of Precision Medicine

Intra-tumour diversification in colorectal cancer at the single-cell level